UConn fans said the Barstool show brought a burst of attention to a program used to playing second fiddle to basketball.
Abbott’s WGS-based Oncodetect MRD test showed a 30% sensitivity improvement for post-surgical colorectal cancer recurrence.
And how you can lower the risk of one of the most deadly cancers by 69%.
AbbVie (NYSE: ABBV) today announced the U.S. Food and Drug Administration has approved a subcutaneous (SC) induction regimen ...
The FDA today approved a subcutaneous induction regimen for AbbVie's Skyrizi (risankizumab-rzaa) in adults with moderately to ...
It's a good time to play Crystal Palace. That, at least, is the crumb of comfort being nibbled at on Tyneside. The more ...